ASTELLAS PHARMA Stock Forecast - Simple Regression

YPHA Stock  EUR 12.30  0.20  1.65%   
The Simple Regression forecasted value of ASTELLAS PHARMA UNSPADR on the next trading day is expected to be 12.24 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 12.80. ASTELLAS Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of ASTELLAS PHARMA's historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of ASTELLAS PHARMA's share price is above 70 as of 18th of January 2026. This entails that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling ASTELLAS, making its price go up or down.

Momentum 72

 Buy Stretched

 
Oversold
 
Overbought
The successful prediction of ASTELLAS PHARMA's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of ASTELLAS PHARMA and does not consider all of the tangible or intangible factors available from ASTELLAS PHARMA's fundamental data. We analyze noise-free headlines and recent hype associated with ASTELLAS PHARMA UNSPADR, which may create opportunities for some arbitrage if properly timed.
Using ASTELLAS PHARMA hype-based prediction, you can estimate the value of ASTELLAS PHARMA UNSPADR from the perspective of ASTELLAS PHARMA response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of ASTELLAS PHARMA UNSPADR on the next trading day is expected to be 12.24 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 12.80.

ASTELLAS PHARMA after-hype prediction price

    
  EUR 12.3  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of ASTELLAS PHARMA to cross-verify your projections.

ASTELLAS PHARMA Additional Predictive Modules

Most predictive techniques to examine ASTELLAS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ASTELLAS using various technical indicators. When you analyze ASTELLAS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through ASTELLAS PHARMA price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

ASTELLAS PHARMA Simple Regression Price Forecast For the 19th of January

Given 90 days horizon, the Simple Regression forecasted value of ASTELLAS PHARMA UNSPADR on the next trading day is expected to be 12.24 with a mean absolute deviation of 0.21, mean absolute percentage error of 0.07, and the sum of the absolute errors of 12.80.
Please note that although there have been many attempts to predict ASTELLAS Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ASTELLAS PHARMA's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

ASTELLAS PHARMA Stock Forecast Pattern

Backtest ASTELLAS PHARMAASTELLAS PHARMA Price PredictionBuy or Sell Advice 

ASTELLAS PHARMA Forecasted Value

In the context of forecasting ASTELLAS PHARMA's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ASTELLAS PHARMA's downside and upside margins for the forecasting period are 10.47 and 14.01, respectively. We have considered ASTELLAS PHARMA's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
12.30
12.24
Expected Value
14.01
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of ASTELLAS PHARMA stock data series using in forecasting. Note that when a statistical model is used to represent ASTELLAS PHARMA stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.4734
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2098
MAPEMean absolute percentage error0.0205
SAESum of the absolute errors12.7994
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as ASTELLAS PHARMA UNSPADR historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for ASTELLAS PHARMA

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ASTELLAS PHARMA UNSPADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.5312.3014.07
Details
Intrinsic
Valuation
LowRealHigh
9.6211.3913.16
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ASTELLAS PHARMA. Your research has to be compared to or analyzed against ASTELLAS PHARMA's peers to derive any actionable benefits. When done correctly, ASTELLAS PHARMA's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ASTELLAS PHARMA UNSPADR.

Other Forecasting Options for ASTELLAS PHARMA

For every potential investor in ASTELLAS, whether a beginner or expert, ASTELLAS PHARMA's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ASTELLAS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ASTELLAS. Basic forecasting techniques help filter out the noise by identifying ASTELLAS PHARMA's price trends.

ASTELLAS PHARMA Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ASTELLAS PHARMA stock to make a market-neutral strategy. Peer analysis of ASTELLAS PHARMA could also be used in its relative valuation, which is a method of valuing ASTELLAS PHARMA by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

ASTELLAS PHARMA UNSPADR Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ASTELLAS PHARMA's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ASTELLAS PHARMA's current price.

ASTELLAS PHARMA Market Strength Events

Market strength indicators help investors to evaluate how ASTELLAS PHARMA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ASTELLAS PHARMA shares will generate the highest return on investment. By undertsting and applying ASTELLAS PHARMA stock market strength indicators, traders can identify ASTELLAS PHARMA UNSPADR entry and exit signals to maximize returns.

ASTELLAS PHARMA Risk Indicators

The analysis of ASTELLAS PHARMA's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ASTELLAS PHARMA's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astellas stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in ASTELLAS Stock

ASTELLAS PHARMA financial ratios help investors to determine whether ASTELLAS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ASTELLAS with respect to the benefits of owning ASTELLAS PHARMA security.